Kythera Biopharma (KYTH) Initial Recommendation Outperform Analyst rating from FBR Capital

30. October 2013

Jazz Pharma (JAZZ) Initial Recommendation Outperform Analyst rating from FBR Capital

30. October 2013

Hipcricket (HIPP) Initial Recommendation Buy Analyst rating from Ladenburg Thalmann

30. October 2013

Hannon Armstrong Sust. Infr. (HASI) Initial Recommendation Buy Analyst rating from UBS

30. October 2013

Forest Labs (FRX) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Endo Health (ENDP) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Ecolab (ECL) Initial Recommendation Buy Analyst rating from UBS

30. October 2013

DS Healthcare Group (DSKX) Initial Recommendation Buy Analyst rating from Aegis Capital

30. October 2013

Biogen Idec (BIIB) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Amarin (AMRN) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Alkermes (ALKS) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Aegerion Pharma (AEGR) Initial Recommendation Outperform Analyst rating from FBR Capital

30. October 2013

Acorda Therapeutics (ACOR) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

30. October 2013

Vertex Pharm (VRTX) Downgrade from Buy to Neutral – Analyst rating from Summer Street Research

30. October 2013

Union Pacific (UNP) Downgrade from Outperform to Neutral – Analyst rating from Robert W. Baird

30. October 2013

U.S. Steel (X) Downgrade from Buy to Hold – Analyst rating from Deutsche Bank

30. October 2013

Rosetta Genomics (ROSG) Downgrade from Buy to Hold – Analyst rating from Aegis Capital

30. October 2013

Questcor Pharma (QCOR) Downgrade from Buy to Fair Value – Analyst rating from CRT Capital

30. October 2013

InterActiveCorp (IACI) Downgrade from Buy to Hold – Analyst rating from Stifel

30. October 2013

Dana Holding (DAN) Downgrade from Buy to Fair Value – Analyst rating from CRT Capital

30. October 2013

Cirrus Logic (CRUS) Downgrade from Equal Weight to Underweight – Analyst rating from Barclays

30. October 2013

Bed Bath & Beyond (BBBY) Downgrade from Buy to Hold – Analyst rating from Canaccord Genuity

30. October 2013

AVG Tech (AVG) Downgrade from Buy to Hold – Analyst rating from BWS Financial

30. October 2013

[FED] MAeRKTE EUROPA/Berg- und Talfahrt vor Fed-Entscheidung – VW gefragt

30. October 2013

Pfizer kaufen – New Analyst Rating from Independent Research GmbH

30. October 2013

[FED] MAeRKTE USA/Vor Fed-Entscheid befaellt die Anleger Hoehenangst

30. October 2013

[FED] MAeRKTE USA/Wall Street weiter auf Rekordjagd vor Fed-Entscheidung

30. October 2013

[FED] MAeRKTE EUROPA/Anleger zuversichtlich vor Fed-Entscheidung

30. October 2013

Tochter BHF ohne Blackrock kaufen

30. October 2013

[AXP] Treasury says taxpayers GM bailout loss now $9.7B

29. October 2013

IBM PC pioneer William C Lowe dies

29. October 2013

Sky takes on Netflix with £4.99 Now TV entertainment package

29. October 2013

U.S. stocks open higher; Pfizer rises 1%

29. October 2013

Apple, Yahoo lead techs up; Seagate falls

29. October 2013

Sicherheitsluecken : Microsoft stellt Support fuer Windows XP ein

29. October 2013

Earnings Beat for Pfizer in 3Q, Updates Outlook

29. October 2013

Jim Cramers 6 Stocks in 60 Seconds: BP SBUX CL HLF TEVA LINE

29. October 2013

Bits Blog: As Microsoft Looks On, Nokia Reports a Rise in Smartphone Sales

29. October 2013

AKTIEN NEW YORK: S&P mit Rekord Pfizer an Dow Spitze Apple schwach

29. October 2013

The Dow Climbs As Pfizer and AT&T Lift the Market

29. October 2013

[AT&T] The Dow Climbs As Pfizer and AT&T Lift the Market

29. October 2013

Aktien New York: S&P mit Rekord Pfizer an Dow Spitze Apple schwach

29. October 2013

Marketing to Millennials: 5 Ways Coca Cola is Embracing Creativity and Innovation

29. October 2013

Boeing muss ersten 777 Jet fuer Lufthansa nachbessern

29. October 2013

Apple, Icahn and the Cash Pile: Manjoo vs. Berman

29. October 2013